X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
TTK HEALTHCARE Fact Sheet, TTK HEALTHCARE Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE Fact Sheet   (TTKP)

Here is the latest financial fact sheet of TTK HEALTHCARE. For more details, see the TTK HEALTHCARE quarterly results and TTK HEALTHCARE share price and chart. For a sector overview, read our pharmaceuticals sector report.

TTK HEALTHCARE Price History

Price Rs 1,275.8
Mkt Cap Rs m 9,913
Vol '000 6.7
P/E X 50.3
P/CF X 63.7
EPS (TTM) Rs 25.3
% ch % -2.3
No. of shares m 7.77
% ch week % 36.9
% ch 1-mth % 52.8
% ch 12-mth % 48.3
52 week H/L Rs 1,457.7/685.0
(As on Feb 19, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

TTK HEALTHCARE Financials

No. of Mths
Year Ending
12
Mar-10
12
Mar-11
12
Mar-12
12
Mar-13
12
Mar-14
5-Yr Chart
Click to enlarge
TTK HEALTHCARE EQUITY SHARE DATA
High Rs304473681598663 
Low Rs95255350330399 
Sales per share (Unadj.) Rs327.5400.2455.3492.0535.6 
Earnings per share (Unadj.) Rs11.819.020.118.315.9 
Diluted earnings per shareRs11.719.020.118.315.9 
Cash flow per share (Unadj.) Rs14.221.523.221.820.0 
Dividends per share (Unadj.) Rs3.504.004.004.004.00 
Adj. dividends per shareRs3.474.004.004.004.00 
Dividend yield (eoy) %1.81.10.80.90.8 
Book value per share (Unadj.) Rs84.097.5112.9126.4137.6 
Adj. book value per shareRs83.397.5112.9126.4137.6 
Shares outstanding (eoy) m7.707.777.777.777.77 
Bonus/Rights/Conversions  BB---- 
Price / Sales ratio x0.60.91.10.91.0 
Avg P/E ratio x16.919.225.625.433.3 
P/CF ratio (eoy) x14.116.922.321.326.5 
Price / Book Value ratio x2.43.74.63.73.9 
Dividend payout %29.621.119.921.925.1 
Avg Mkt Cap Rs m1,5362,8284,0053,6074,127 
No. of employees `0001.31.51.51.81.7 
Total wages/salary Rs m302368436530607 
Avg. sales/employee Rs Th1,877.92,103.72,336.52,175.92,436.7 
Avg. wages/employee Rs Th224.9249.1287.7301.4355.2 
Avg. net profit/employee Rs Th67.899.7103.280.872.5 
TTK HEALTHCARE INCOME DATA
Net Sales Rs m2,5223,1093,5373,8234,162 
Other income Rs m3844476761 
Total revenues Rs m2,5603,1533,5843,8904,223 
Gross profit Rs m152214238201197 
Depreciation Rs m1820242732 
Interest Rs m1717262530 
Profit before tax Rs m155222236216197 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m6474797473 
Profit after tax Rs m91147156142124 
Gross profit margin %6.06.96.75.34.7 
Effective tax rate %41.333.533.634.337.0 
Net profit margin %3.64.74.43.73.0 
TTK HEALTHCARE BALANCE SHEET DATA
Current assets Rs m1,1591,4821,4611,5441,629 
Current liabilities Rs m7351,0779439991,058 
Net working cap to sales %16.813.014.614.313.7 
Current ratio x1.61.41.51.51.5 
Inventory Days Days3331342630 
Debtors Days Days3338393434 
Net fixed assets Rs m303374393438556 
Share capital Rs m7878787878 
"Free" reserves Rs m454565685791878 
Net worth Rs m6477578779821,069 
Long term debt Rs m0656159 
Total assets Rs m1,5441,9291,9242,0942,399 
Interest coverage x10.113.910.29.57.6 
Debt to equity ratio x00000.1 
Sales to assets ratio x1.61.61.81.81.7 
Return on assets %7.08.59.58.06.4 
Return on equity %14.119.517.814.511.6 
Return on capital %26.631.329.624.518.5 
Exports to sales %0.70.70.71.20.8 
Imports to sales %2.11.00.91.21.4 
Exports (fob) Rs m1721264733 
Imports (cif) Rs m5432324758 
Fx inflow Rs m1721264733 
Fx outflow Rs m5636375163 
Net fx Rs m-39-15-11-4-30 
TTK HEALTHCARE CASH FLOW
From Operations Rs m 190 254 62 244 127 
From Investments Rs m -112 -71 -43 -5 -146 
From Financial Activity Rs m -88 -68 -9 -20 22 
Net Cashflow Rs m -9 115 10 218 3 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 65.4%
Foreign collaborators 0.0%
Indian inst/Mut Fund 3.7%
FIIs 5.2%
ADR/GDR 0.0%
Free float 25.8%
Shareholders 12,723
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF No.6, Cathedral Road, Chennai - 600 086
E-MAIL skr@ttkhealthcare.com WEB www.ttkhealthcare.com
TELEPHONE (044) 2811 6106 FAX (044) 2811 6387
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Data Software, 19, Pycrofts Garden Road, Nungambakkam, Chennai-06
AUDITOR Aiyar & Co.
CHM: T. T. Jagannathan COMP SEC: S. Kalyanaraman YEAR OF INC: 1958 BSE CODE: 507747 FV (Rs): 10 DIV YIELD (%): 0.3

More Pharmaceuticals Company Fact Sheets:   TORRENT PHARMA  SANOFI INDIA  LUPIN LTD  WYETH LTD  PLETHICO PHARMA  

Compare TTK HEALTHCARE With:   TORRENT PHARMA  SANOFI INDIA  LUPIN LTD  WYETH LTD  PLETHICO PHARMA  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of PNB Fraud, Rising Troubles at PSBs, and Top Cues in Focus Today(Pre-Open)

Share markets in India closed on a negative note yesterday. At the closing bell yesterday, the BSE Sensex stood lower by 236 points and the NSE Nifty closed down by 74 points.

Views on news

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - ACTAVIS COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS